Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05337241 · ClinicalTrials.gov registry record · NA
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
A NA study of Refractory Ventricular Tachycardia, sponsored by Thermedical.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 7
- Study locations
NCT05337241 is a NA study of Refractory Ventricular Tachycardia that is actively recruiting participants, run by Thermedical. The registered enrollment target is 130 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT05337241, a NA study of Refractory Ventricular Tachycardia, is actively recruiting participants, sponsored by Thermedical.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 7
- Study locations
Study Summary
The Thermedical Ablation System and Durablate catheter is indicated for use in patients with recurrent, sustained, monomorphic ventricular tachycardia (SMVT) refractory to drug therapy and conventional (approved) catheter ablation. Subjects with recurrent, SMVT refractory to drug therapy and conventional catheter ablation who are not eligible for, or will not likely benefit from repeat endocardial ablation using an approved catheter.
Conditions Studied
Interventions
- DEVICE Saline Enhanced Radiofrequency (SERF) Ablation
Study Locations (7)
Quebec
- Montreal Heart Institute - Institut de Cardiologie de Montréal - Montreal
- Quebec Heart and Lung Institute - Institut universitaire de cardiologie et de pneumologie de Québec - Québec
Alabama
- University of Alabama at Birmingham - Birmingham
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
South Carolina
- Medical University of South Carolina - Charleston
Tennessee
- Vanderbilt University Medical Center - Nashville
Utah
- Intermountain Healthcare - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-08-09 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05337241
The ClinicalTrials.gov registry entry for NCT05337241 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thermedical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Refractory Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Saline Enhanced Radiofrequency (SERF) Ablation is the first listed.
NCT05337241 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Quebec, Alabama, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05337241 about?
NCT05337241 is a clinical study titled "Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT". The Thermedical Ablation System and Durablate catheter is indicated for use in patients with recurrent, sustained, monomorphic ventricular tachycardia (SMVT) refractory to drug therapy and conventional (approved) catheter ablation. Subjects with recurrent, SMVT refractory to drug therapy and conven...
What is the current status of trial NCT05337241?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2025-08-09. Estimated completion is 2027-06-30.
What conditions does trial NCT05337241 study?
This clinical trial studies the following conditions: Refractory Ventricular Tachycardia.
What interventions are being tested in trial NCT05337241?
The interventions under investigation include: Saline Enhanced Radiofrequency (SERF) Ablation (DEVICE).
Who is sponsoring clinical trial NCT05337241?
This trial is sponsored by Thermedical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05337241 being conducted?
This trial has 7 study locations across Alabama, Pennsylvania, South Carolina, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.